|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5000 CAD | 0.00% |
|
-1.96% | +9.89% |
| 03/06 | PharmaCorp Rx Initiated at Outperform, $0.70 Price Target at Raymond James | MT |
| 01/06 | Earnings Flash (PCRX.V) PharmaCorp Reports Q1 Revenue $7.2M, Up 79.4% YoY | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 0.6667 | +33.33% | 3 | ||||||
| 62.03 | +88.8% | 16 | ||||||
| 5.061 | +67.77% | 17 | ||||||
| 2,979 | +24.75% | 10 | ||||||
| 33.72 | +59.56% | 12 | ||||||
| 350.38 | +48.94% | 8 | ||||||
| 125.87 | +32.01% | 9 | ||||||
| 24.49 | +48.86% | 8 | ||||||
| 43.17 | +2.85% | 6 | ||||||
| - | - | 1,415 | +204.3% | 1 | ||||
| 36.02 | +10.2% | 8 | ||||||
| 74.28 | +53.91% | 9 | ||||||
| 1,168.71 | +35.98% | 7 | ||||||
| 58.31 | +34.74% | 7 | ||||||
| 14.86 | +34.74% | 5 | ||||||
| - | 90 | +20% | 2 | |||||
| - | 5,350 | +55.75% | 2 | |||||
| Average | 695.97 | +50.38% | 8 | ||||||
| Weighted average by Cap. | 533.72 | +62.77% | 11 |
- Stock Market
- Stocks
- PCRX Stock
- Sector PharmaCorp Rx Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
